547 research outputs found

    Spinocerebellar Ataxia Type 6.

    No full text

    Additional copies of the Ef-Tu and Aspartyl-tRNA synthetase genes can compensate a mutation affecting the maturation of the mitochondrial tRNAAsp

    No full text
    In an attempt to identify new nuclear genes involved in the synthesis and processing of mitochondrial tRNAs, we utilized a multicopy nuclear library to suppress the heat-sensitive phenotype of a Saccharomyces cerevisiae mitochondrial mutant strain. This strain (Ts 932) is defective in the 3¢-end processing of the mitochondrial tRNAAsp transcript. The nuclear genes coding for the mitochondrial elongation factor Tuf M and for the mitochondrial aspartyl-tRNA synthetase have been found to restore the temperature-resistant phenotype and to correct the RNA processing defect. Suppression was effective even when the genes were present on a centromeric plasmid

    Valutazione del risultato estetico di impianti a connessione morse-taper nei settori frontali

    No full text
    Lo studio presenta i dati estetici di impianti a connessione conometrica inseriti nei settori frontali dei mascellari con un protocollo di carico immediato non funzional

    Spinocerebellar ataxia type 6 and episodic ataxia type 2: differences and similarities between two allelic disorders

    No full text
    Spinocerebellar ataxia type 6 (SCA6) is one of three allelic disorders caused by mutations of CACNA1A gene, coding for the pore-forming subunit of calcium channel type P/Q. SCA6 is associated with small expansions of a CAG repeat at the 3' end of the gene, while point mutations are responsible for its two allelic disorders (Episodic Ataxia type 2 and Familial Hemiplegic Migraine). Genetic, clinical, pathological and pathophysiological data of SCA6 patients are reviewed and compared to those of other SCAs with expanded CAG repeats as well as to those of its allelic channelopathies, with particular reference to Episodic Ataxia type 2. Overall SCA6 appears to share features with both types of disorders, and the question as to whether it belongs to polyglutamine disorders or to channelopathies remains unanswered at present

    Cancer in perianal fistulas

    No full text
    The presence of a perianal fistula as a complication related to Crohn's disease (CD) was first described by Penner and by Burrill Crohn himself in 1938 [1]. Since then, intense efforts have been made and significant economic resources spent in order to improve the quality of life of patients with inflammatory bowel diseases (IBDs) who also have perianal fistulas. Unfortunately, the results have been poor regardless of the medical or surgical treatment adopted. The incidence of perianal disease is 20-25% in CD patients with terminal ileitis, but it increases to as high as 60% in CD with a colonic location and 92% when the rectum is actively involved [2-4]. In ulcerative colitis (UC) perianal suppurative lesions are less common, but the incidence of perianal abscesses and fistulas is still reported to be between 10% and 15% [5]
    corecore